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Abstract
In B. burgdorferi, the Rrp2-RpoN-RpoS signaling cascade is a distinctive system that coor-
dinates the expression of virulence factors required for successful transition between its
arthropod vector and mammalian hosts. Rrp2 (BB0763), an RpoN specific response regula-
tor, is essential to activate this regulatory pathway. Previous investigations have attempted
to identify the phosphate donor of Rrp2, including the cognate histidine kinase, Hk2
(BB0764), non-cognate histidine kinases such as Hk1, CheA1, and CheA2, and small
molecular weight P-donors such as carbamoyl-phosphate and acetyl-phosphate (AcP). In a
report by Xu et al., exogenous sodium acetate led to increased expression of RpoS and
OspC and it was hypothesized this effect was due to increased levels of AcP via the enzyme
AckA (BB0622). Genome analyses identified only one pathway that could generate AcP in
B. burgdorferi: the acetate/mevalonate pathway that synthesizes the lipid, undecaprenyl
phosphate (C55-P, lipid I), which is essential for cell wall biogenesis. To assess the role of
AcP in Rrp2–dependent regulation of RpoS and OspC, we used a unique selection strategy
to generate mutants that lacked ackA (bb0622: acetate to AcP) or pta (bb0589: AcP to
acetyl-CoA). These mutants have an absolute requirement for mevalonate and demon-
strate that ackA and pta are required for cell viability. When the ΔackA or Δptamutant was
exposed to conditions (i.e., increased temperature or cell density) that up-regulate the
expression of RpoS and OspC, normal induction of those proteins was observed. In addi-
tion, adding 20mM acetate or 20mM benzoate to the growth media of B. burgdorferi strain
B31 ΔackA induced the expression of RpoS and OspC. These data suggest that AcP (gen-
erated by AckA) is not directly involved in modulating the Rrp2-RpoN-RpoS regulatory path-
way and that exogenous acetate or benzoate are triggering an acid stress response in B.
burgdorferi.
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Introduction
B. burgdorferi, the agent of Lyme disease in North America, persists in nature in various reser-
voir animals (e.g., Peromyscus species) and is spread to new hosts by a hematophagous arthro-
pod vector (Ixodes species) [1, 2]. As the bacterium evolved to a parasitic lifestyle, it
sequentially reduced its genome by shedding the genes encoding enzymes used to synthesize
essential precursors for RNA, DNA, proteins, lipoproteins and lipids [3]. This effectively locked
the bacteria into a host-dependent existence and eliminated the possibility of returning to a
“free-living” lifestyle. Successful transmission of B. burgdorferi between its vector and mamma-
lian hosts requires that the bacteria adapt to changing environmental conditions. Bacteria
being acquired by the vector modulate gene expression to promote survival in the tick midgut
[4, 5]. During subsequent feeding of ticks colonized by B. burgdorferi, the bacteria again alter
gene expression to promote effective transmission to a new host [4]. Successful transmission of
the bacterium to a mammal requires the expression of genes regulated by the Rrp2-RpoN-RpoS
regulatory system [6].
First described by Hubner et al., the Rrp2-RpoN-RpoS signaling pathway coordinates the
expression of virulence factors that allow B. burgdorferi to transition between its vector and
mammalian hosts [7, 8]. Rrp2 is a response regulator protein that is activated by phosphoryla-
tion and associates with the sigma factor RpoN to form a complex that activates RNA polymer-
ase (RNAP) [6, 8]. This Rrp2-RpoN-RNAP complex then activates the expression of the
alternate sigma factor RpoS which coordinates expression of key virulence factors that are
required for initial infection of the mammalian host [6, 9, 10].
Investigations attempting to identify the phosphate donor for Rrp2 have shown that the
cognate histidine kinase (Hk2) and non-cognate Hk1 as well as CheA1, CheA2, and carba-
moyl-P were likely not involved [9, 11]. However, the addition of sodium acetate (30, 60, 90
mM) to the growth media resulted in activation of the Rrp2-RpoN-RpoS cascade. It was
hypothesized that the Rrp2 activation was due to an increase in the intracellular concentration
of acetyl-phosphate (AcP) produced by acetate kinase (encoded by ackA or bb0622). AckA
converts acetate to AcP, which is subsequently converted to acetyl-CoA (AcCoA) by phosphate
acetyltransferase (encoded by pta or bb0589). AcCoA is then condensed to mevalonate for cell
wall synthesis [3, 12]. There have been many reports linking AcP to the activation of response
regulator proteins [11, 13–16]. However, it is extremely difficult to measure intracellular AcP
concentrations in bacteria and Xu et al. were not able to demonstrate that the addition of
sodium acetate to the growth medium increased the intracellular concentration of AcP [11,
17].
In this article, we characterize the genes responsible for acetate utilization in B. burgdorferi.
While the complete pathway that converts acetate to undecaprenyl phosphate (C55-P) is
described here, we have focused on the first enzymes in the pathway, AckA and Pta. Because
this is the only pathway that allows B. burgdorferi to utilize acetate, mutations in ackA and pta
allowed the generation of spirochetes unable to produce AcP or AcCoA. Using these mutants,
it was then possible to directly assess the role of AcP in the activation of the Rrp2-RpoN-RpoS
signaling pathway. Here we demonstrate that the loss of ackA and pta had no effect on acetate-
, temperature-, or cell density-dependent regulation of the Rrp2-RpoS-RpoN regulatory path-
way. Further, analysis of these mutants suggested that the increased activation of the
Rrp2-RpoN-RpoS cascade after exposure to acetate is likely due to an acid stress response
rather than phosphorylation of Rrp2 by AcP. Based upon the data presented in this study, we
conclude that the acetate/mevalonate pathway in B. burgdorferi is used to generate undecapre-
nyl phosphate (C55-P) and subsequently lipid II, a peptidoglycan precursor, and that the inter-
mediate AcP is not involved in the regulation of the Rrp2-RpoS-RpoN regulatory cascade.
Acetate Pathway in B. burgdorferi
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Results
Utilization of acetate by B. burgdorferi
Analysis of the genome of B. burgdorferi identified a complete pathway that encodes enzymes
capable of converting acetate to C55-P, a peptidoglycan precursor (Fig 1). The genes bb0622
(ackA) and bb0598 (pta) encode enzymes that catalyze the first two steps of this pathway (Fig
1, shaded area). Acetate kinase (AckA) enzymatically catalyzes the conversion of acetate to
AcP using a phosphate donated by ATP. Then, phosphate acetyl transferase (Pta) converts
AcP to AcCoA which is then condensed to acetoacetyl-CoA and shuttled through the pathway
to eventually form lipid II for cell wall biogenesis (Fig 1). In most bacteria, AcCoA and AcP are
generated from pyruvate. However, no homolog of pyruvate dehydrogenase has been identified
in B. burgdorferi, suggesting that it is not able to convert pyruvate to AcCoA to generate ATP.
In addition, acetate has not been identified as an end product of fermentation in B. burgdorferi
[18]. It has been previously shown that B. burgdorferi is sensitive to vancomycin, a molecule
that binds to and sequesters lipid II (the peptidoglycan precursor ultimately produced by this
pathway) [19, 20]. Vancomycin prevents the incorporation of N-acetylglucosamine (GlcNAc)-
N-acetylmuramic acid (MurNAc)-pentapeptide into newly synthesized peptidoglycan [19, 20].
Fig 1. The putative pathway for the synthesis of undecaprenyl-P (C55-P) in B. burgdorferi. A schematic
diagram showing the proposed pathway for the conversion of acetate to C55-P and its role in cell wall
biogenesis. Mevalonate, the intermediate that was added to the plating BSK II to isolate mutants, is
highlighted. The genes ackA and pta are highlighted by shadowing.
doi:10.1371/journal.pone.0144472.g001
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Sensitivity to vancomycin in vitro (MICs: 0.5–2 ug/ml) provides experimental evidence that B.
burgdorferi synthesizes a lipid II moiety structurally similar to other vancomycin sensitive bac-
teria [20]. These observations and the lack of genes encoding enzymes for fatty acid oxidation
strongly suggest that the proposed pathway for the synthesis of lipid II is the only way to gener-
ate AcP and AcCoA in B. burgdorferi.
Initial characterization of the ackA and pta loci
It has been proposed that AcP can act as a global signaling molecule in B. burgdorferi by donat-
ing a phosphate to Rrp2 and thereby activating the Rrp2-RpoN-RpoS network of genes [11].
To determine the effect of AcP on gene regulation, ackA and ptamutants were constructed in
wild-type B. burgdorferi strain B31-A3. In this way, a mutant strain that could not produce
AcP or AcCoA by disrupting ackA, and a mutant that could over-produce AcP by disrupting
pta, were generated. Previously, it has been shown that over-expression of Pta had an effect on
the expression of genes regulated by the Rrp2-RpoN-RpoS cascade [11]. Since the purpose of
this study was to evaluate the role of AcP as a global regulator, it was desirable to complement
ΔackA and Δpta using their native promoters to ensure “wild-type” levels of AckA and Pta.
Therefore, primer extension analyses were done on RNA isolated from cells harvested in mid-
log phase of growth. Analyses showed (four independent biological replicates) that ackA had
only one transcriptional start site, 42 nucleotides upstream of the predicted start codon
(packA, Fig 2A). Analysis of pta was not as clear; multiple assays showed that the transcrip-
tional start for ptamost commonly mapped 208 bps 5’ to the translational start of pta and
inside the upstream gene, bb0588 (ppta2, Fig 2B). The promoter reported by Sze and Li (ppta1,
Fig 2B) is located 5’ to the translational start of bb0588 but was not identified in any of the anal-
yses performed [21]. In addition, despite multiple attempts, RT-PCR reactions with primers
adjacent to the translational start for pta, failed to detect transcripts spanning the entire length
of bb0588 and pta. Fig 2B depicts the transcriptional start reported here as well as the start
reported by [21].
The deletion of ackA and pta was accomplished by homologous recombination using allelic
exchange vectors that contained the upstream and downstream regions of each target gene
flanking the aacC1 (gentamycin) or aadA (streptomycin) resistance cassettes, respectively (Fig
3A and 3D). Mutants were grown in BSKII plating media, supplemented with 10 mMmevalo-
nolactone. This supplement allowed the mutants to survive by bypassing the need for acetate
while providing a key intermediate for the synthesis of C55-P and cell wall biogenesis (Fig 1).
ΔackA and Δptamutants were isolated and screened for plasmid content and insertion of their
respective antibiotic resistance cassettes (Fig 3B and 3E). ΔackA and Δptamutants isogenic to
the parent strain were selected for further characterization. Using data from the primer exten-
sion analyses, plasmids pCR200 (ackA) and pCR201 (pta) were constructed so that both genes
would be expressed from their native promoters and both mutant strains (ΔackA and Δpta)
were complemented as described in the materials and methods. The genetic makeup of the
mutants and their corresponding complements were confirmed by PCR of genomic DNA (Fig
3B and 3E) and by qRT-PCR (Fig 3C and 3F) (Table 1). Strains ΔackA::pCR200 and Δpta::
pCR201 were missing plasmid lp25.
The ΔackA and Δptamutants require mevalonolactone for growth and
viability
To generate ΔackA and Δpta, the metabolite mevalonolactone was required as a supplement in
the BSKII growth medium. Commercially available mevalonolactone undergoes hydrolysis by
water and forms an equilibrium between mevalonolactone and mevalonate at neutral pH.
Acetate Pathway in B. burgdorferi
PLOSONE | DOI:10.1371/journal.pone.0144472 December 17, 2015 4 / 19
After diffusing into the cell, mevalonate is converted to phosphomevalonate by mevalonate
kinase (bb0688) and is then presumed to generate C55-P (Fig 1). Since C55-P is essential for
growth, strains ΔackA and Δpta should have an absolute requirement for exogenous mevalo-
nate. The requirement for mevalonate was tested in strains B31-A3, ΔackA, Δpta, ΔackA::
pCR200 and Δpta::pCR201 (Fig 4). All strains were grown in BSKII supplemented with
increasing concentrations of mevalonolactone (10 nM to 10 mM). The minimum concentra-
tion of mevalonolactone that could support growth and viability of ΔackA and Δpta was
100 μM; cells exposed to concentrations below that threshold showed decreased viability, even-
tually leading to cell death (Fig 4). The addition of mevalonolactone did not appear to effect
the growth of wild-type B. burgdorferi and complementation of ΔackA and Δpta resulted in a
complete restoration of growth and viability without mevalonolatone in the growth medium
(Fig 4).
Influence of the ackA and ptamutations on RpoS and OspC expression
following a shift in growth temperature
Previous studies have attempted to identify potential phosphodonors in B. burgdorferi that
activate Rrp2 and stimulate the RpoN-RpoS regulatory cascade [9, 11]. B31-A3, ΔackA and
Δpta, and their respective complemented strains were assayed for changes in the transcription
Fig 2. Transcriptional start sites of ackA and pta. (A) Genomic region and sequence indicating the
mapped transcriptional start site of ackA (designated packA). (B) Genomic region and sequence including the
mapped transcript start sites of pta [designated ppta1 (reported by Sze and Li, [21]) and ppta2 from this
report]. The putative -35/-10, the ribosome binding site (rbs) and translational start site are underlined for
each gene.
doi:10.1371/journal.pone.0144472.g002
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and translation of rpoS and ospC under conditions that have been shown to activate the
Rrp2-RpoN-RpoS regulatory cascade [4, 5, 22]. One environmental signal/condition known to
activate the Rrp2-RpoN-RpoS regulatory cascade is an increase in temperature (24–34°C).
Fig 3. Generating the ΔackA and Δptamutants. (A) and (D) Schematic representations of the allelic
exchange events that were used to delete ackA and pta, respectively. (B) PCR of genomic DNA isolated from
B. burdorferi strain B31-A3, ΔackA or ΔackA::pCR200. Lane 1: Hyperladder I, Lanes 2 and 3: the ackA locus
was amplified from DNA from strain B31-A3 (lane 2) or ΔackA (lane 3) using primers P1 and P4. Lanes 4 and
5: the gentamicin resistance gene, aacC1, was amplified from DNA isolated from ΔackA (lane 4) or ΔackA::
pCR200 (lane 5) using primers P17 and P18. (C) RT-PCR on DNase treated RNA isolated from the
designated strains using primers P21and P22. (+ or -) denotes reactions with or without reverse
transcriptase. (E) PCR of genomic DNA isolated from strains B31-A3, Δpta and Δpta::pCR201. Lane 1,
Hyperladder I, Lanes 2 and 3, the pta locus amplified from genomic DNA from strain B31-A3 (lane 2) or Δpta
(lane 3) using primers P15 and P16. Lanes 4 and 5 the streptomycin resistance gene, aadA, was amplified
using primers P19 and P20 from DNA from Δpta (lane 4) and Δpta::pCR201 (lane 5). (F) RT-PCR on DNase
treated RNA isolated from the designated strains using primers P23 and P24. (+ or -) denotes reactions with
or without reverse transcriptase.
doi:10.1371/journal.pone.0144472.g003
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Table 1. Strains, vectors, and primers used in this study.
Strains Reference
Borrelia burgdorferi B31-A3 (Low Passage) [39]
Borrelia burgdorferi B31-A3 ΔackA This study
Borrelia burgdorferi B31-A3 Δpta This study
Borrelia burgdorferi B31-A3 ΔackA::pCR200 This study
Borrelia burgdorferi B31-A3 Δpta::pCR201 This study
Escherichia coli TOP10 Invitrogen
Plasmids Reference
pPCR-Script Cam SK(+) Agilent
pBSV2G [40]
pKFSS1 [41]
pCR100 (pPCR-Script Cam SK+::ΔackA::aacC1) This study
pCR101 (pPCR-Script Cam SK+::Δpta::aadA) This study
pCR200 (pKFSS1::ackA) This study
pCR201 (pBSV2G::pta) This study
Primer Sequence 5'–3' Reference
1. ackA1-kpnI ACTGCTGGTACCAGGTGTTGGCAATTTACTTGG This study
2. ackA1-xhoI ACTGCTCTCGAGGTTATGTGCTTGTTTTTAGTAAGT This study
3. ackA1-claI ACTGCTATCGATTAATTTACAATTTTAAAAACTAAAATCT This study
4. ackA1-pstI ACTGCTCTGCAGTGCAAATGGCTTTGAAGATATTGAGG This study
5. ackA2-kpnI ACTGCTGGTACCGTGGATTTATTCCTGAAAATTATG This study
6. ackA2-sphI ACTGCTGCATGCTAAATTTTTTGGAATTAAATTATAAATGTC This study
7. ackA-F CAGGGCTTTGGAAATAGAATACA This study
8. ackA-R GGTCTTCTAGGATTCAATAAGTTTACATGTTATCC This study
9. pta1-kpnI ACTGCTGGTACCTTAATTCTGGCGTTGCTGGT This study
10. pta1-xhoI ACTGCTCTCGAGCGGGAAAAACTATATTGGCCTTA This study
11. pta1-claI ACTGCTATCGATGCCCATTAGCGATCTTTCAA This study
12. pta1-pstI ACTGCTCTGCAGAACCGCATTTGAAATTGACTT This study
13. pta2-xhoI ACTCTCGAGTTTAATGCCAATAAAAATTTAATTAAGAATGC This study
14. pta2-pvuI ACTCGATCGTTAAATGCTTATCATTAAAGC This study
15. pta-F GTTGTACAAGAAATTTTAAG This study
16. pta-R CATTACCAATAAAGCTACTCTG This study
17. aacC1-xhoI ACTGCTCTCGAGTAATACCCGAGCTTCAAGGA This study
18. aacC1-claI ACTGCTATCGATTTAGGTGGCGGTACTTGGGTCGAT This study
19. aadA-xhoI ACTGCTCTCGAGTACCCGAGCTTCAAGGAA This study
20. aadA-claI ACTGCTATCGATTTATTTGCCGACTACCTTG This study
21. ackA-RTF TGCAATCACCGCAATAGAAG This study
22. ackA-RTR GAAAGGCCATGAAAGCCATA This study
23. pta-RTF TGCAGCTTGATTCAGCCATA This study
24. pta-RTR CCTTGGCAAAAGCAAATCTC This study
25. rpoD-RTF GCAGGCTGAAAATTGAAAAA This study
26. rpoD-RTR CAAGTTCTTTTTGGGCAAGC This study
27. ospC-RTF TGCGGTTTTACTTGCTGTGA This study
28. ospC-RTR ATTGCATAAGCTCCCGCTAA This study
29. rpoS-RTF AGGCAATGCAAAAGCAAAAA This study
30. rpoS-RTR TCGGGTCATATTTTTCAGCA This study
31. ackA-GSP1 GCTTGATCCTCCATGTACAAC This study
32. ackA-GSP2 GCTAAGAGTTTTAAGGATTTT This study
(Continued)
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After a shift from 24°C to 34°C, gene transcript levels were assayed by qRT-PCR in B. burgdor-
feri B31-A3, ΔackA, Δpta, ΔackA::pCR200 and Δpta::pCR201. Cultures were harvested after 4,
8, 24, and 48 hours (prior to cultures reaching stationary phase) in order to distinguish temper-
ature-dependent RpoS activation from cell density-dependent regulation. rpoS and ospC tran-
script levels were compared with transcript levels of cells grown at 24°C and normalized to
rpoD transcripts. As shown in Fig 5A, when compared with cultures maintained at 24°C, there
was slight variation in rpoS transcript between all five strains tested at the early time points (4
and 8h). At 24 and 48h post shift in growth temperature, all five strains had similar increases of
rpoS transcription. At 48h post temperature shift, rpoS transcription increased dramatically
(~7 to 10-fold) as cells reached a cell density of ~7–9 x 107 cells ml-1. The observed changes in
ospC transcript levels followed patterns similar to that observed with rpoS transcripts (Fig 5B).
However, there was more variability between strains at the 4 and 8h time points when com-
pared to rpoS transcript levels. Each strain showed increased ospC transcript levels, similar to
trends seen in wild-type strains as described previously [9].
Immunoblot analyses were also used to assess RpoS and OspC synthesis in the five B. burg-
dorferi strains following an increase in growth temperature. RpoS levels were virtually unde-
tectable at early time points but increased with time as cultures were incubated at 34°C (Fig
5C). OspC could be detected at every time point assayed and increased concomitantly with an
increase in rpoS and ospC expression. Although there was minor variation, there were no dra-
matic differences in protein profiles of the five strains. Each strain increased the RpoS and
Table 1. (Continued)
33. pta-GSP1 CCCTTTAACTTTTGTAAACTC This study
34. pta-GSP2 CTGGGAAAGAATTAGGAT This study
35. pta-GSP3 GCAATTAGAAAATTCTTT This study
The underlined sequence identiﬁes the restriction site within each primer.
doi:10.1371/journal.pone.0144472.t001
Fig 4. Growth and survival ofB. burgdorferiB31-A3,ΔackA, Δpta, ΔackA::pCR200 and Δpta::pCR201 in the presence and absence of
mevalonolactone.Growth of strains B31-A3, ΔackA, and Δack::pCR200 (A) and B31-A3, Δpta, and Δpta::pCR201 (B) in BSKII supplemented with
increasing concentrations of mevalonolactone (0–10 mM, shown in parentheses). Cells were quantified by culture in BSKII plating media supplemented with
10 mMmevalonolactone.
doi:10.1371/journal.pone.0144472.g004
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OspC levels in response to growth at an increased temperature, consistent with previous studies
[9, 22]. Overall, these qRT-PCR and immunoblot analysis suggest that AcP, synthesized by
AckA, was not required to activate the Rrp2-RpoN-RpoS cascade following a temperature shift.
Influence of the ackA and ptamutations on RpoS and OspC expression
when B. burgdorferi cells reached stationary phase/maximum cell
density
It has been observed that as B. burgdorferi cells reach stationary phase/maximum cell density,
the expression of RpoS and RpoS-regulated genes (e.g., dbpA, ospC) increases. To examine the
role of the ackA and ptamutations on cell density-dependent regulation of rpoS and ospC,
qRT-PCR was used to monitor transcript levels in B31-A3, ΔackA, Δpta, ΔackA::pCR200, and
Δpta::pCR201 as the cell density increased. RNA was harvested from cell cultures at approxi-
mately 1 x 107, 2 x 107, 5 x 107, 1 x 108, and 2 x 108 cells ml-1. Transcript levels were compared
to the initial cell density (1 x 107 cells ml-1) and normalized to rpoD transcripts. At low cell den-
sities, 1–5 x 107 cells ml-1, rpoS and ospC transcripts did not change significantly and no differ-
ence was observed between the strains (Fig 6A and 6B). As cells reached maximum cell density,
1–2 x 108 cells ml-1, all strains showed a dramatic increase in rpoS and ospC transcripts. No sig-
nificant difference was observed between the strains.
The levels of RpoS and OspC were analyzed by immunoblot in strains B31-A3, ΔackA,
Δpta, ΔackA::pCR200, and Δpta::pCR201 at different cell densities (Fig 6C). RpoS levels were
Fig 5. Quantitative RT-PCR of rpoS and ospC and immunoblot analysis of RpoS and OspC in strains B31-A3,ΔackA, Δpta, Δack::pCR200 and
Δpta::pCR201 after an increase in growth temperature. (A) RT-PCR analysis of rpoS and (B) ospC transcripts in B31-A3,ΔackA, ΔackA::pCR200, Δpta,
and Δpta::pCR201, after a temperature shift from 24°C to 34°C. Samples were collected at 0, 4, 8, 24, and 48h and transcript levels were compared to
expression at 24°C. (C) Immunoblot analysis of RpoS and OspC in each strain after a temperature shift and sampling at the indicated time points.
Immunoblots were probed with antiserum specific for RpoS, OspC and FlaB. FlaB was included as a protein load control for each assay.
doi:10.1371/journal.pone.0144472.g005
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low at low cell densities and increased as cells reached 1 x 108 cells ml-1 for each strain tested.
OspC could also be detected at low levels at lower densities and increased concomitantly with
an increase in rpoS, ospC and RpoS levels. Taken together, these results showed that the mutant
strains, ΔackA and Δpta, are able to up-regulate rpoS, ospC, RpoS, and OspC, as cells reached
stationary phase/maximum cell density as observed in the wild-type cells. These data suggest
the AcP generated by AckA does not affect cell density-dependent regulation in B. burgdorferi.
The proposed phosphate donor for Rrp2 is AcP. Phosphorylation of Rrp2 activates RpoN,
which in turn up-regulates rpoS and its regulon of virulence genes. qRT-PCR and immunoblot
data suggested that deleting the gene (ackA) encoding the only known way to enzymatically
Fig 6. Effect of increasing cell density on rpoS and ospC transcript, RpoS and OspC protein expression, and levels of Rrp2 phosphorylation. (A)
and (B) QRT-PCR analysis of rpoS and ospC transcripts in B31-A3, ΔackA, Δpta, Δack::pCR200 and Δpta::pCR201 as each strain increased in cell density
from 1 x 107 to 2 x 108 cells ml-1. (C) Immunoblot analysis of RpoS and OspC levels in each strain as cell density increased. Immunoblots were probed with
antiserum specific for RpoS, OspC and FlaB. (D) Phos-Tag1 SDS-PAGE and immunoblot analysis of Rrp2 phosphorylation levels in B31-A3 and ΔackA in
mid-log and stationary phases of growth. Phosphorylated (Rrp2-P) and non-phosphorylated (Rrp2) proteins are indicated on the right. FlaB was included as
protein load control for each assay.
doi:10.1371/journal.pone.0144472.g006
Acetate Pathway in B. burgdorferi
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synthesize AcP in B. burgdorferi had no effect on temperature- or cell density-dependent gene
regulation. This suggested that in ΔackA, the levels of phosphorylated Rrp2 (Rrp2-P) were
unaffected by the loss of AckA and AcP. To test this hypothesis, cells were harvested at mid-log
and stationary/maximum cell density phase of growth and assayed for the levels of Rrp2-P. As
cells transitioned from mid-log to maximum cell density, the ratio of non-phoshorylated Rrp2
to Rrp2-P shifts dramatically in B31-A3 and ΔackA (Fig 6D). More importantly, deleting ackA
had no effect on the phosphorylation levels of Rrp2 at different stages of growth, confirming
the qRT-PCR and immunoblot data. Taken together, these data strongly suggest that AcP does
not play a significant role in cell density-dependent regulation through the Rrp2-RpoN-RpoS
regulatory cascade.
The absence of ackA did not change the effect of exogenous sodium
acetate on RpoS and OspC levels
Previous studies have shown that the addition of 20–90 mM sodium acetate at pH 7.0 leads to
an increase in both rpoS and ospC transcript and RpoS and OspC protein levels in wild-type B.
burgdorferi cells [11, 23]. In those studies, it was suggested that the addition of acetate stimu-
lated the production of AcP via AckA, leading to an increase in Rrp2-P and activating the
Rrp2-RpoN-RpoS regulatory cascade. To assess the effect of exogenous acetate on RpoS and
OspC expression, B31-A3 and ΔackA were exposed to increasing concentrations of sodium
acetate (0, 30, and 60 mM) at pH 7.0. Both B31-A3 and ΔackA showed increased RpoS and
OspC expression when they were exposed to increasing concentrations of sodium acetate (Fig
7A), similar to previous reports. In addition, high concentrations of sodium acetate (30 and 60
mM) slowed the growth of both B31-A3 and ΔackA, while lower concentrations did not affect
growth (S1 Fig). Previously, in E.coli, it has been shown that weak permeant acids such as ace-
tate or benzoate can trigger rapid changes in intracellular pH, leading to changes in gene regu-
lation [24]. To assess whether sodium benzoate would elicit a similar response as sodium
Fig 7. Effect of acetate on RpoS and OspC expression and Rrp2 phosphorylation. (A) Immunoblot
analysis of RpoS and OspC in B31-A3 and ΔackA in the presence of 0, 30, and 60 mM sodium acetate. (B)
Immunoblot analysis of RpoS and OspC in B31-A3 and ΔackA in the presence of 0 and 20 mM sodium
benzoate. In each panel, FlaB was included as a protein load control.
doi:10.1371/journal.pone.0144472.g007
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acetate in B. burgdorferi, B31-A3 and ΔackA were incubated with 20 mM sodium benzoate.
Similar to the expression observed with the addition of sodium acetate (Fig 7A), both strains
showed an increase in RpoS and OspC levels when 20 mM sodium benzoate was added to the
growth medium (Fig 7B).
ackA and pta are required for infectivity in immunocompetent mice
To assess the infectivity of B31-A3, ΔackA, and Δpta, each strain was inoculated by intradermal
injection into five RML mice (a closed colony of Swiss-Webster mice used at the RML since
1937) (3 separate replicates for a total of 15 mice injected per strain). B31-A3 was isolated from
all of the mouse tissues tested (ankle joint, bladder, and skin). However, ΔackA and Δpta were
non-infectious and were not isolated from any of the tissues tested. As previously shown, the
Rrp2-RpoN-RpoS cascade appears to function normally in ΔackA and Δpta (Figs 5 and 6), so
the inability of these strains to colonize mice is most likely due to other factors independent of
Rrp2-RpoN- RpoS-dependent regulation. Because ΔackA and Δpta require mevalonolactone
for survival in vitro, it is possible that the inability to colonize a mouse is due to very low levels
of mevalonate in blood and tissue. We have previously shown that these mutants require a
minimum of 100 μMmevalanolactone to survive in vitro (Fig 4). While the levels of mevalo-
nate are difficult to assess in mice, experimental data has shown that the mevalonate concentra-
tions in humans range from 28–43 nM, well below the levels required for the survival of ΔackA
and Δpta [25], (http://www.hmdb.ca/metabolites/HMDB00227).The inability of these mutants
to survive in vivo is most likely due to low levels of mevalonate in the host rather than a direct
result of mutations in ackA or pta affecting gene regulation through the Rrp2-RpoN-RpoS reg-
ulatory cascade.
Discussion
Acetate, AcP, and AcCoA are key metabolites in central metabolism, cell signaling and gene
regulation in many eukaryotes, prokaryotes and some species of Archaea [16, 26, 27]. Most
commonly, these molecules are produced during fermentation (acetogenesis). Typically, pyru-
vate dehydrogenase converts pyruvate to AcCoA and NAD+, with AcCoA being converted to
AcP by phosphate acetyltransferase (Pta) and to acetate by acetate kinase (AckA) [16]. While
Borrelia species have ackA and pta homologs, they do not appear to be using Pta and AckA for
acetogenesis. There are several lines of evidence to support this conclusion. First, B. burgdorferi
are homo-fermenters catabolizing glucose to lactate with no production of acetate [28, 29]. Sec-
ond, they do not harbor a gene encoding pyruvate dehydrogenase. Third, they do not harbor
genes encoding pyruvate oxidase or pyruvate formate lyase, which are enzymes capable of gen-
erating AcCoA from pyruvate. Finally, they harbor no genes encoding proteins for β-oxidation
of fatty acids or a TCA cycle to generate and consume AcCoA for energy. Taken together,
these data suggest a different role for ackA and pta in B. burgdorferi.
The utilization or activation of acetate in Archaea or Bacteria involves four possible path-
ways. In acetoclastic methanogens (e.g.,generaMethnosarcina), AckA, Pta and CO dehydroge-
nase/AcCoA synthase convert acetate to CO2 and CH4 [26]. Acetate uptake/utilization in
Bacteria can be accomplished using: (i) irreversible AcCoA synthetase (AMP-forming) that
generates AcCoA in a two-step reaction; (ii) irreversible AcCoA synthetase (ADP-forming) in
a single step; or (iii) via the the Ack-Pta pathway. The B. burgdorferi genome does not contain
genes annotated as AcCoA synthetase, indicating that acetate activation requires AckA and
Pta. Due to the limited metabolic capabilities of B. burgdorferi, AcCoA, generated by these
enzymes, appears to be used exclusively for the synthesis of mevalonate and activated isopren-
oids. Ultimately, these isoprene units are condensed to C55-P for cell wall biogenesis (see Fig
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1). The genome of B. burgdorferi harbors genes encoding enzymes for the complete synthesis
of C55-P, lipid I, lipid II and peptidoglycan. While the enzymes required for the completion of
the final steps of this pathway have not been characterized experimentally, evidence suggests
that the downstream portion of the pathway is intact and functions as annotated. Lipid II mole-
cules are susceptible to certain antibiotics, such as vancomycin, which binds and disrupts lipid
II function, leading to cell death in bacteria containing this structure [20]. B. burgdorferi is sen-
sitive to vancomycin and exposure to the drug disrupts cell integrity [19, 30]. Bacteria require
significant amounts of lipid II for cell wall biosynthesis and growth, synthesizing up to 2 x 105
copies of C55-P per cell [31, 32]. Using the pathway described above, B. burgdorferi uses an esti-
mated 66 ATPs to synthesize one lipid II molecule representing a huge investment in energy to
produce the required amount of this essential lipid [20, 31, 32].
The role of acetate in cell wall biogenesis in B. burgdorferi seemed to be quite clear. How-
ever, recent studies suggested a role for AcP in the Rrp2-RpoN-RpoS regulatory cascade [11,
23]. It had been proposed that low molecular weight phosphate donors, such as AcP, might
play an important role in Rrp2-dependent regulation by directly phosphorylating Rrp2 inde-
pendent of its cognate histidine kinase Hk2 [9, 11]. Previous experiments attempted to manip-
ulate the intracellular concentration of AcP by adding sodium acetate to the growth media [11,
23]. In those studies, increasing concentrations of sodium acetate stimulated the synthesis of
RpoS and OspC, suggesting that this is the case. However, it was not possible to measure the
intracellular AcP concentration to confirm that exogenous acetate was responsible for the
observed increase in RpoS and OspC.
AcP is a high energy form of phosphate and possesses a higher energy of hydrolysis than
ATP [16]. Several studies have investigated the role of AcP in signal transduction via response
regulator proteins [13, 15, 33]. In those reports, AcP acts as a high energy phosphate donor to
response regulator proteins in vitro. However, under in vivo conditions, the contribution of
AcP to response regulator activation is seen only when cognate histidine kinases are not pres-
ent [i.e., null mutations and/or under very specific growth conditions] [16, 34]. Additionally, E.
coli has multiple pathways that use or generate AcCoA and AcP, making it difficult to study
the effects of AcP on global regulation [16]. This is not the case with B. burgdorferi. Due to its
limited metabolic capabilities, AcP and AcCoA can only be derived from the linear pathway
that synthesizes C55-P for cell wall assembly. To better understand the role of AcP in cell sig-
naling in B. burgdorferi, ackA or pta was deleted in strain B31-A3. These mutants were selected
by including mevalonolactone, an intermediate in the C55-P pathway, in the growth media.
Growth experiments confirmed that ΔackA and Δpta had an absolute requirement for mevalo-
nate and established that these genes were essential for the replication and viability of B. burg-
dorferi. More importantly, the strains allowed the evaluation of the putative role of AcP in
mutants which are unable to synthesize AcP (ΔackA) or could overproduce AcP (Δpta) while
maintaining a genetic background in which the cognate histidine kinase (Hk2) for Rrp2 was
intact.
To analyze the role of AcP in cell signaling through the Rrp2-RpoN-RpoS cascade, experi-
ments were conducted under conditions known to activate expression of the Rrp2-RpoN-R-
poS-dependent genes. RpoS and its regulon has been shown to be activated in response to
increases in temperature (23–34°C) and as cells reach maximum cell density (~2–3 X 108 cells
ml-1) in vitro [4, 10, 35]. These laboratory conditions are meant to mimic conditions the spiro-
chete encounters as it transitions from its tick vector to a mammalian host. When B31-A3,
ΔackA, Δpta, ΔackA::pCR200, and Δpta::pCR201 were exposed to a change in temperature or
as the cells approached and reached maximum cell density, no significant differences were
observed in the transcripts or the protein levels for rpoS, ospC, RpoS and OspC. In every case,
the genes and proteins were activated similarly to wild-type cells, suggesting the AckA and Pta
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were not directly involved in these regulatory signals. However, there are several tiers of tran-
scriptional, translational and post-translational regulation on rpoS, ospC, RpoS and OspC after
Rrp2 is initially phosphorylated [7, 9, 36–38]. To complete these studies, we directly assayed
the levels of Rrp2-P in the wild-type and ΔackA strains as cells reached maximum cell density.
No differences were observed in the ratio of Rrp2 and Rrp2-P in B31-A3 or ΔackA, suggesting
that AcP was not required for phosphorylation of Rrp2. Taken together, these data strongly
suggest that AckA and Pta, or the products of their enzymatic activity (AcP and AcCoA), do
not appear to be required to modulate the levels of Rrp2-P or to activate the Rrp2-RpoN-RpoS
cascade under the conditions tested.
Xu et al. used high concentrations of acetate in B. burgdorferi to attempt to influence the
intracellular concentration of AcP and assess its potential as a small molecular weight phos-
phate donor for Rrp2 [11]. When high concentrations of acetate were added to the growth
medium, an increase in RpoS and OspC was observed and attributed to increased levels of cyto-
plasmic AcP. However, when strains B31-A3 and ΔackA were exposed to high concentrations
(30 and 60 mM) of sodium acetate, production of RpoS and OspC were the same in both
strains. These data raised a fascinating question. If high concentrations of sodium acetate
increased the production of RpoS and OspC independent from the intracellular concentration
of AcP, what was the effect being observed? Wilks and Slonczewski, using GFP and YFP gene
fusions, were able to show that the addition of high concentrations of sodium acetate (20mM)
to these E. coli reporter strains triggered a very rapid fall in intracellular pH (7.5–5.5) [24].
Sodium benzoate elicited a similar response in the E.coli strains tested, showing that the intra-
cellular pH did not recover from exposure to permeant organic acids. When B31-A3 and
ΔackA cells were exposed to 20 mM sodium benzoate, an increase in the synthesis of RpoS and
OspC was observed in both strains, similar to the increase that was observed with the addition
of sodium acetate. Therefore, we believe that the addition of sodium acetate to B. burgdorferi is
not triggering increased levels of RpoS and OspC via AcP, but instead that weak permeant
acids are initiating a pH/acid stress response modulated by increased levels of RpoS. Currently,
we are investigating the mechanism responsible for the regulation of the acid stress response in
B. burgdorferi.
Experimental Procedures
Bacterial Strains, Culture Conditions and Reagents
E. coli was used for cloning and plasmid maintenance. B. burgdorferi strain B31-A3 [39] and
derivatives were grown in Barbour-Stoenner-Kelly medium (BSKII) at pH7.6 or pH6.8 at 34°C
unless stated otherwise. Spirochetes were enumerated by dark-field microscopy. Antibiotics
were used at the following concentrations: chloramphenicol and gentamicin at 20 μg ml-1,
streptomycin at 50 μg ml-1, and spectinomycin at 100 μg ml-1. All chemicals were purchased
from Sigma-Aldrich (St Louis, MO) unless stated otherwise.
Generation of B31-A3ΔackA (bb0622) and B31-A3Δpta (bb0589)
Mutants and Complementing Vectors
Approximately 0.6 kb of DNA 5’ and 3’ of ackA (bb0622) or pta (bb0589) open reading frames
were amplified by PCR using primers 1 & 2 and 3 & 4 for ackA and 9 & 10 and 11 & 12 for pta
(Table 1). The aacC1 and aadA genes, including the flgB promoter, were amplified by PCR
from pBSV2G or pKFSS1 respectively, using primers 17 & 18 or 19 & 20 (Table 1). To generate
pCR100 (pPCR-Script Cam::ΔackA::aacC1) and pCR101 (pPCR-Script Cam::Δpta::aadA) for
allelic exchange, the upstream region, antibiotic resistance cassette (flgBp-aacC1 for ΔackA or
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flgBp-aadA for Δpta) and downstream region of each targeted gene were sequentially cloned
into pPCR-Script Cam SK(+) (Agilent Technologies, Cedar Creek, TX) using appropriate
restriction enzymes. Relevant plasmid sequences were confirmed by sequencing (ACGT Inc.,
Wheeling, IL). Wild type B. burgdorferi was transformed with pCR100 or pCR101 as previously
described [39] and transformants were selected by plating in BSKII medium supplemented
with 10 mMmevalonolactone and the appropriate antibiotic. Antibiotic resistance cassette
insertion sites were confirmed by PCR using primers 7 & 8 (ΔackA) or 15 & 16 (Δpta)
(Table 1).
The B31-A3ΔackA and B31-A3Δpta strains, subsequently referred to as ΔackA and Δpta
respectively, were complemented using pCR200 (pKFSS1::ackA) or pCR201 (pBSV2G::pta)
respectively. Briefly, ackA and 600 bp of DNA 5’ of the coding region, or the pta gene and 423
bp of DNA 5’ to the coding region were amplified by PCR using primers 5 & 6 or 13 & 14
(Table 1) and cloned into appropriately digested pKFSS1 [41] or pBSV2G [40], respectively.
The resulting plasmids, pCR200 or pCR201, were transformed into ΔackA or Δpta as previ-
ously described and transformants were plated in BSKII medium (lacking mevalonolactone)
and containing the appropriate antibiotics. PCR and sequencing (ACGT Inc.) was used to con-
firm both strains.
Mevalonolactone Dependence, Temperature Shift, Cell Density and
Acid Stress Experiments
B31-A3, ΔackA, Δpta, ΔackA::pCR200 and Δpta::pCR201 were analyzed for their ability to sur-
vive and replicate in BSKII media with or without mevalonolactone as well as to determine the
minimummevalonolactone concentration required for growth. Cultures were grown in 50 ml
BSKII (+10 mMmevalonolactone) to mid-logarithmic phase and cells were washed three times
with HN buffer (20 mMHEPES, pH 7.6, 50 mMNaCl) to remove residual mevalonolactone.
Equivalent spirochete numbers were inoculated into BSKII media containing varying concen-
trations of mevalonolactone. Growth and survival was determined using viable cell counts,
assayed by plating in BSKII (+10mMmevalonolactone) solid media.
Temperature shift experiments were performed as previously described with minor modifi-
cations [42, 43]. Briefly, B. burgdorferi strains were grown in 10 ml of BSK II (pH 6.8) at 23°C
under a microaerobic atmosphere (90%N2, 5% CO2, 5% O2) to mid-log phase and expanded to
500 ml at 1 x 106 cells ml-1. Cultures were grown to 1 x 107 cells ml-1 and then shifted to 34°C.
Samples were harvested for RNA and protein analysis at 0, 4, 8, 24, and 48 h time points follow-
ing the temperature shift. The pH of the culture medium after 48 h of incubation was 6.8.
For cell density experiments, B. burgdorferi cultures were grown in 10 ml of BSK II medium at
pH 6.8 under a microaerobic atmosphere to mid log phase and subsequently expanded to 500 ml
at 1 x 106 cells ml-1. Aliquots were harvested for RNA and protein analysis at cell densities of
1 x 107 cells ml-1, 2 x 107 cells ml-1, 5 x 107 cells ml-1, 1 x 108 cells ml-1, and 2 x 108 cells ml-1. Two
10 ml samples were harvested at each time point or cell density for RNA and protein analysis.
Growth of B. burgdorferi in increasing concentrations of extracellular sodium acetate or
sodium benzoate was performed as previously described [11]. Briefly, B. burgdorferi B31-A3
and ΔackA were grown from frozen stock in BSK II containing 10 mMmevalonolactone at pH
6.8 under microaerobic conditions. Cells were subcultured to a density of approximately 2 x
106 cells ml-1 in BSK II containing 10 mMmevalonolactone and either increasing concentra-
tions of sodium acetate (0, 30, and 60 mM) or sodium benzoate (0 and 20 mM). B31-A3 and
ΔackA cells were incubated with acetate or benzoate until cell density reached approximately
2 x 107 cells ml-1 at which point each culture was harvested for western blot analysis (described
below).
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RNA Extraction and Quantitative Reverse Transcription Polymerase
Chain Reaction (qRT-PCR)
Samples for RNA analysis were harvested at 4°C by centrifugation, the cell pellet resuspended
in Trizol solution and the RNA extracted according to the manufacturer’s instructions (Invi-
trogen, Grand Island, NY). RNA samples were subsequently treated with TURBO DNase
(Ambion, Austin, TX), following the manufacturer’s instructions. Quantitative RT-PCR was
performed using a one-step QuantiTect SYBR Green kit (Qiagen) following the manufacturer’s
instructions. To confirm gene deletions, ackA and pta transcripts were assayed in WT, ΔackA,
Δpta and their complements using primers 21–24 (Table 1). To amplify rpoD, ospC and rpoS
transcripts, primers 25–30 were used (Table 1). cDNA was synthesized at 42°C for 30 minutes
and denatured at 95°C for 15 minutes. Quantitative RT-PCR was performed under standard
conditions on a LightCycler (Roche, Indianapolis, IN). The LightCycler software was used for
the analysis of fold changes and rpoD normalization.
SDS-PAGE Gel Electrophoresis, Immunoblot and Phos-tag analysis
Protein samples were prepared by harvesting cells by centrifugation (8,000 x g, 10 min, 4C),
washing the cell pellet with HN buffer and lysis in B-per lysis solution (Merck KGaA, Darm-
stadt, Germany). Cell debris was removed by centrifugation and the supernatant was collected.
Protein concentration was quantified by absorbance and equivalent amounts were loaded onto
4–20% Tris-HEPES polyacrylamide gels (NuSep, Bogart, GA). Proteins were transferred to
nitrocellulose membranes (Invitrogen) and immunoblot analysis was performed as previously
described (Burtnick et al. 2007). Proteins were visualized with the ECLTM Plus Western Blot-
ting Detection Reagents (GE Healthcare, Pittsburgh, PA). Primary antibodies were used at the
following concentrations: α-RpoS polyclonal antiserum (1:200), α-OspC polyclonal antiserum
(1:1000), α -flagellin monoclonal antibody (H9724 1:50) [44], Rrp2 polyclonal antiserum
(1:200) [22].
Rrp2 phosphorylation was assessed using Phos-tag analysis [45]. Bacterial cells grown to
mid-log and stationary phase as described above and were harvested by centrifugation. The cell
pellets were resuspended in SDS-PAGE loading buffer and loaded onto gels containing 75 μM
Phos-TagTM acrylamide and 150 μMZn(NO3)2. Following electrophoresis, the gels were
washed 15 min in transfer buffer (25 mM Tris, 192 mM glycine, 1mM EDTA), and 15 min in
transfer buffer without EDTA before transferring to a nitrocellulose membrane.
Promoter Analysis of ackA and pta using 5’-primer Extension Analyses
Primer extension analysis was performed using the 5’ RACE kit (Invitrogen) according to the
manufacturer’s instructions. Briefly, cDNA synthesis was performed using gene specific prim-
ers (GSP) listed in Table 1. cDNA was purified and used in TdT reactions that added a poly-
cytosine tail to the 5’ end of the cDNA. Tailed cDNA was subsequently used in PCR reactions
with an internal GSP primer (ackA-GSP2 or pta-GSP2—Table 1) and an abridged anchor
primer provided by Invitrogen. PCR products were analyzed on an agarose gel, purified on a
Qiaquick PCR purification column (Qiagen) and subjected to Sanger sequencing (ACGT Inc.).
Analysis of Infectivity of ΔackA and Δpta in a Murine Model
B. burgdorferi B31-A3 and mutant strains were grown to mid log phase and three groups of
five female RML mice were obtained from the Rocky Mountain Laboratories Veterinary
Branch (RMVB) breeding facility. Each mouse was inoculated by intradermal injection with an
inoculum of 5 x 105 cells grown in BSKII. The mice used in this study were monitored regularly
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with health checks occurring twice daily. Inocula were plated to confirm dose and plasmid con-
tent. Three weeks post-inoculation, ear punch biopsies were performed. Seven to 14 days fol-
lowing initial screening, mice were anesthetized by inhalation of isoflurane and, while under
anesthesia, were euthanized humanely by cervical dislocation. Tissues from the ear, bladder,
liver, and ankle joint tissues were cultured in BSK II containing 10 mMmevalonolactone to
test for spirochete positive tissue. Mouse infection studies were carried out in accordance with
guidelines of the National Institutes of Health. All animal work was done according to proto-
cols approved by the Rocky Mountain Laboratories Animal Care and Use Committee (Protocol
Number 2014–021).
Supporting Information
S1 Fig. Effect of acetate on growth of B. burgdorferi. (A) Growth of B31-A3 and (B) ΔackA,
respectively in the presence of 0, 30, and 60 mM exogenously added sodium acetate.
(TIF)
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